Rock Health is a San Francisco-based digital health organization that combines venture investing, research, and ecosystem convening. Its investment arm focuses on pre-seed through Series A digital health startups, while its broader platform gives it outsized visibility into healthcare technology trends. It is more digital-health-centric than deep neurotech-specific.

The firm does not operate a dedicated neurotechnology thesis, but its portfolio and research activities make it relevant to software, diagnostics, remote monitoring, and digital therapeutics that intersect with brain health. Its real strength lies in market intelligence, ecosystem access, and understanding how new technologies are adopted in healthcare systems. That can be highly valuable for neurotech companies with software-heavy or care-delivery components.

Rock Health focuses mainly on US-based startups. For neurotech founders, it is most relevant to digital neurology, mental health software, patient monitoring, and care platforms rather than implantables or frontier neuroengineering. It is a useful strategic investor for companies operating closer to digital health than to hard neurodevices.